Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

4 results about "Erythrina" patented technology

Erythrina /ˌɛrɪˈθraɪnə/ is a genus of flowering plants in the pea family, Fabaceae. It contains about 130 species, which are distributed in tropical and subtropical regions worldwide. They are trees, with the larger sp[ecies growing up to 30 m (98 ft) in height. The generic name is derived from the Greek word ερυθρóς (erythros), meaning "red", referring to the flower color of certain species.

Ervatamia divaricata extract, preparation method thereof and application of ervatamia divaricata extract in resisting brain metastatic tumor

The invention provides an ervatamia divaricata extract as well as a preparation method and application of the ervatamia divaricata extract in resisting brain metastatic tumor. Pharmacological activity shows that the extract of ervatamia divaricata disclosed by the invention has remarkable cytotoxicity inhibition activity, and the inhibition effect of the extract is time-dependent and dose-dependent. The extract can inhibit the growth of breast cancer 4T1 brain metastases, and has no obvious adverse reaction on mice.
Owner:CHINESE MEDICINE GUANGDONG LABORATORY +1

Application of Erythrina bark in the preparation of drugs for the prevention and / or treatment of infectious coryza in chickens

This invention provides the application of Erythrina bark in the preparation of drugs for the prevention and / or treatment of infectious coryza in chickens. The active ingredient of this drug can be composed solely of Erythrina bark, making the formulation easy and convenient to implement. It can be used as a substitute for antibiotics during the egg-laying period of chickens, with no drug residue requirements, reducing the economic loss of discarded eggs after the use of antibiotics in laying hens. It has a high cure rate for infectious coryza, is safe and has no toxic side effects, and is easy to use.
Owner:BEIJING CENT BIOLOGY CO LTD +1

Traditional Chinese medicine composition for treating gout and pill preparation thereof

The invention relates to a traditional Chinese medicine composition for treating gout and a pill preparation thereof, the composition takes rhizoma smilacis glabrae and corn stigma as monarch drugs, Chinese actinidia root, fructus polygoni orientalis and the like as ministerial drugs, and erythrina bark, fructus viticis and the like as adjuvant drugs, and the synergistic effect of reducing uric acid and resisting inflammation is realized through scientific compatibility. Experiments show that the preparation can significantly reduce the blood uric acid level of gout model animals, inhibit ankle joint swelling and improve the symptoms of patients through clinical verification, and the safety is superior to that of a traditional western medicine scheme. The technical problems that an existing traditional Chinese medicine preparation is single in target spot and obvious in side effect are solved, and a new solution is provided for gout treatment.
Owner:TONGHUA KANGYUAN BIOLOGICAL TECH

Euphorbia milii

ActiveCN309982525SErythrinaIndustrial engineering
1. Name of the designed product: handicraft (small erythrina). 2. Use of the designed product: decorative statue. 3. Design points of the designed product: in shape. 4. Picture or photo best indicating the design points: perspective view.
Owner:QUANZHOU KUSI MEDIA CO LTD